AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES

Balance Sheet
Fiscal Year: 2025
Jul 1, 2024 – Jun 30, 2025
Assets in 2025 (Year End)
$35,063,665
Investments
67%
Property, Plant, & Equipment (net)
12%
Cash & Equivalents
10%
Receivables (Non-Related)
7%
Other Assets
2%
Prepaid Expenses
2%
Related-Party Receivables
0%
Inventories
0%
Liabilities in 2025 (Year End)
$6,901,088
Deferred Revenue
70%
Payables & Accruals
21%
Other Liabilities
8%
Grants Payable
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Assets
2024
2025
Change
Cash & Equivalents
$2,345,229
$3,397,773
+45%
Receivables (Non-Related)
$2,410,713
$2,478,865
+3%
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
$632,169
$651,330
+3%
Investments
$24,135,737
$23,520,345
-3%
Property, Plant, & Equipment (net)
$4,439,925
$4,227,194
-5%
Other Assets
$280,793
$788,158
+181%
Total Assets
$34,244,566
$35,063,665
+2%
Liabilities
2024
2025
Change
Payables & Accruals
$860,237
$1,480,248
+72%
Grants Payable
-
-
-
Deferred Revenue
$4,520,340
$4,841,311
+7%
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
$349,468
$579,529
+66%
Total Liabilities
$5,730,045
$6,901,088
+20%
Net assets
2024
2025
Change
Restricted Net Assets
$5,043,943
$5,342,854
+6%
Unrestricted Net Assets
$23,470,578
$22,819,723
-3%
Net assets
2024
2025
Change
Net assets
+$28,514,521
+$28,162,577
-1%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)